Realm Therapeutics PLC Block listing Interim Review (2001Q)

TIDMRLM

RNS Number : 2001Q

Realm Therapeutics PLC

18 February 2019

Realm Therapeutics plc

Block Listing Interim Review

Pursuant to AIM Rule 29 and Schedule 6 of the AIM Rules for Companies Realm Therapeutics plc makes the following update on its block listing:

Date: 18 February 2019

 
 Name of applicant:                                       Realm Therapeutics plc 
 Name of scheme:                                   Executive Omnibus           Warrants 
                                                     Incentive Plan 
                                                Figures for all schemes relate to ordinary 
                                                                  shares 
                                                             of 10 pence each 
                                              --------------------------------------------- 
 Period of return:                                 From: 18 August 2018 To: 15 February 
                                                                   2019 
                                              --------------------------------------------- 
 Balance of unallotted securities 
  under scheme(s) from previous return:                         2,055,362        21,257,021 
                                              ---------------------------  ---------------- 
 Plus: The amount by which the block 
  scheme(s) has been increased since 
  the date of the last return (if 
  any increase has been applied for):                                 Nil               Nil 
                                              ---------------------------  ---------------- 
 Less: Number of securities issued/allotted 
  under scheme(s) during period:                                      Nil               Nil 
                                              ---------------------------  ---------------- 
 Equals: Balance under scheme(s) 
  not yet issued/allotted at end of 
  period:                                                       2,055,362        21,257,021 
                                              ---------------------------  ---------------- 
 
 
 Number and class of securities originally            *20,000 and       *196,087 and 
  admitted:                                    *378,423 + *32,000            *21,108 
                                                      and 200,000 
  * these securities have been adjusted 
  for a 1 for 10 share consolidation 
  which took effect on 2 July 2010 
 Dates of Admission:                            7 August 2006 and  7 August 2006 and 
                                               31 August 2007 and     31 August 2007 
                                                   15 August 2012 
                                             --------------------  ----------------- 
 Name of contact:                             Marella Thorell, Company Secretary 
                                             --------------------------------------- 
 Telephone number of contact:                 +1 484-321-2749 
                                             ---------------------------------------

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

BLRGIGDDSXBBGCU

(END) Dow Jones Newswires

February 18, 2019 02:00 ET (07:00 GMT)

Realm Thera. (LSE:RLM)
Graphique Historique de l'Action
De Déc 2024 à Jan 2025